SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-Jun-23 4:00 PM View: | Prometheus Biosciences, Inc. (RXDX) | 16-Jun-23 | Disposition | 178,098 | -- | -- | (100%) 178.1K to 0 | |
02-Jun-23 7:13 PM View: | Prometheus Biosciences, Inc. (RXDX) | 02-Jun-23 | Option Exercise | 122,531 | $2.90 | $355,336.00 | 221% 55.51K to 178.04K | |
17-Mar-23 9:02 PM View: | Prometheus Biosciences, Inc. (RXDX) | 15-Mar-23 | Option Exercise | 25,000 | $2.90 | $72,500.00 | 45% 55.14K to 80.14K | |
17-Mar-23 9:02 PM View: | Prometheus Biosciences, Inc. (RXDX) | 15-Mar-23 | Planned Option Sale | 25,000 | $116.14 | $2,903,500.00 | (31%) 80.14K to 55.14K | |
03-Mar-23 10:00 PM View: | Prometheus Biosciences, Inc. (RXDX) | 03-Mar-23 | Option Exercise | 10,620 | $3.70 | $39,294.00 | 19% 55.14K to 65.76K | |
03-Mar-23 10:00 PM View: | Prometheus Biosciences, Inc. (RXDX) | 03-Mar-23 | Planned Option Sale | 10,620 | $125.13 | $1,328,880.00 | (16%) 65.76K to 55.14K | |
03-Mar-23 10:00 PM View: | Prometheus Biosciences, Inc. (RXDX) | 01-Mar-23 | Option Exercise | 700 | $3.70 | $2,590.00 | 1% 55.14K to 55.84K | |
03-Mar-23 10:00 PM View: | Prometheus Biosciences, Inc. (RXDX) | 01-Mar-23 | Planned Option Sale | 700 | $125.26 | $87,682.00 | (1%) 55.84K to 55.14K | |
17-Feb-23 9:31 PM View: | Prometheus Biosciences, Inc. (RXDX) | 17-Feb-23 | Option Exercise | 13,680 | $3.70 | $50,616.00 | 25% 55.14K to 68.82K | |
17-Feb-23 9:31 PM View: | Prometheus Biosciences, Inc. (RXDX) | 17-Feb-23 | Planned Option Sale | 13,680 | $125.10 | $1,711,370.00 | (20%) 68.82K to 55.14K | |
17-Feb-23 9:31 PM View: | Prometheus Biosciences, Inc. (RXDX) | 16-Feb-23 | Option Exercise | 25,000 | $3.70 | $92,500.00 | 45% 55.14K to 80.14K | |
17-Feb-23 9:31 PM View: | Prometheus Biosciences, Inc. (RXDX) | 16-Feb-23 | Planned Option Sale | 25,000 | $119.87 | $2,996,750.00 | (31%) 80.14K to 55.14K | |
17-Feb-23 9:31 PM View: | Prometheus Biosciences, Inc. (RXDX) | 15-Feb-23 | Option Exercise | 25,000 | $2.90 | $72,500.00 | 45% 55.14K to 80.14K | |
17-Feb-23 9:31 PM View: | Prometheus Biosciences, Inc. (RXDX) | 15-Feb-23 | Planned Option Sale | 25,000 | $119.42 | $2,985,500.00 | (31%) 80.14K to 55.14K | |
19-Jan-23 8:39 PM View: | Prometheus Biosciences, Inc. (RXDX) | 17-Jan-23 | Option Exercise | 25,000 | $2.90 | $72,500.00 | 45% 55.14K to 80.14K | |
19-Jan-23 8:39 PM View: | Prometheus Biosciences, Inc. (RXDX) | 17-Jan-23 | Planned Option Sale | 25,000 | $118.99 | $2,974,750.00 | (31%) 80.14K to 55.14K | |
13-Dec-22 8:32 PM View: | Prometheus Biosciences, Inc. (RXDX) | 09-Dec-22 | Grant | 37,113 | -- | -- | 206% 18.03K to 55.14K | |
03-Dec-21 7:02 PM View: | Prometheus Biosciences, Inc. (RXDX) | 01-Dec-21 | Option Exercise | 15,400 | $2.90 | $44,660.00 | 100% 0 to 15.4K | |
21-Aug-19 4:15 PM View: | Valeant Pharmaceuticals Int... (BHC) | 19-Aug-19 | Market Sale | 10,773 | $21.83 | $235,221.00 | (34%) 31.53K to 20.76K | < 1% |
26-Jun-19 4:17 PM View: | Valeant Pharmaceuticals Int... (BHC) | 24-Jun-19 | Payment of Exercise | 1,913 | $23.82 | $45,567.70 | (6%) 33.44K to 31.53K | |
08-May-19 4:16 PM View: | Valeant Pharmaceuticals Int... (BHC) | 06-May-19 | Payment of Exercise | 746 | $23.51 | $17,538.50 | (2%) 34.19K to 33.44K | (8%) |
12-Mar-19 4:38 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Mar-19 | Payment of Exercise | 974 | $23.56 | $22,947.40 | (3%) 35.16K to 34.19K | < 1% |
01-Mar-19 5:13 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-19 | Grant | 15,221 | -- | -- | 76% 19.94K to 35.16K | |
10-Jan-19 4:11 PM View: | Valeant Pharmaceuticals Int... (BHC) | 08-Jan-19 | Payment of Exercise | 1,190 | $21.25 | $25,287.50 | (6%) 21.13K to 19.94K | (12%) |